Nectar Lifesciences LtdPharmaceuticalsINE023H01027Consolidated₹10.93-0.05 (-0.46%)Jun-26
Valuation
Market Cap₹212.33 Cr
TTM PE-3.17x
Forward PE-2.38x
PEG0.09
Book Value₹29.97
P/B0.36x
TTM EPS₹-3.45
Fwd EPS₹-4.59
TTM Revenue₹5.01 Cr
TTM PAT₹-245.06 Cr
TTM EBITDA₹-119.48 Cr
TTM EBIT₹-119.87 Cr
Last Qtr PAT₹-15.40 Cr
Last Qtr EBITDA₹-27.70 Cr
Last Qtr EBIT₹-27.81 Cr
Profitability
ROE-42.08%
ROCE-3.33%
TTM NPM-4891.42%
TTM EBITDA %-2384.83%
Curr OPM-458.33%
Last OPM-896.04%
Curr NPM
Last NPM
Curr EPS₹-0.79
Last EPS₹-3.38
Balance sheet
Equity₹19.43 Cr
Reserve₹562.87 Cr
Total Debt₹0.00 Cr
D/E0.00x
Interest %-1.04%
Curr Interest₹0.16 Cr
Price / range
Close₹10.93
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D-0.46%
1W-4.96%
1M+4.39%
3M-4.46%
6M-0.09%
1Y-31.86%
2Y-74.12%
3Y-56.00%
5Y-61.78%
Diwali-46.60%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1868.90₹4.48L Cr37.0814.50%
DIVISLAB9410.50₹2.50L Cr85.3917.45%
TORNTPHARM4970.00₹1.89L Cr79.3925.70%
ZYDUSLIFE1161.00₹1.16L Cr25.8716.94%
CIPLA1386.10₹1.12L Cr33.219.75%
LAURUSLABS2017.50₹1.09L Cr99.5820.58%
MANKIND2437.80₹1.01L Cr49.2612.68%
DRREDDY1198.30₹1.00L Cr30.978.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue0.01-100.0%005280.670
Other Income6.287.580.660.740.359.29
Total Income6.29-97.8%7.580.665.74281.029.29
Interest0.165.9030.23018.7036.13
Expenditure-27.95+92.6%-64.50-32.21-6.24-377.78-97.16
PBDT000000
EBITDA-27.67+55.3%-58.52-1.92-1.04-61.89-60.69
Depreciation-0.11-0.08-0.06-0.20-16.52-0.34
EBIT-27.78+64.6%-58.60-1.98-1.24-78.41-61.03
PBT-21.65+77.6%-56.9256.60-0.51-96.75-87.87
Tax8.2019.7111.030.1833.5230.53
Equity19.4319.430022.4319.43
OPM-344.20-750.920.00-10.13-34.43-945.76
Net Profit-13.14+79.2%-67.9214.27-176.01-63.23-292.88
NPM-208.90-896.040.00-3522.23-22.50-3152.38
EPS-0.67+76.2%-3.38-2.38-7.83-2.82-2.62

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue0-100.0%1,673.07-0.7%1,685.63+10.6%1,524.61-8.6%1,668.26+8.1%1,542.90
Other Income9.291.8913.0342.2411.292.72
Total Income9.29-99.4%1,674.97-1.4%1,698.66+8.4%1,566.85-6.7%1,679.55+8.7%1,545.62
Expenditure-97.16+94.7%-1,836.50-9.3%-1,680.39-4.5%-1,607.54+2.3%-1,645.20-2.5%-1,604.95
Interest-36.13-74.58-87.14-79.48-78.81-112.03
PBDT000000
EBITDA-60.69-129.4%-26.46-117.3%153.10+175.0%55.67-65.0%158.84+44.1%110.23
Depreciation-0.34-62.39-60.72-59.12-56.97-60.25
EBIT-61.03+31.3%-88.85-196.2%92.38+2777.7%-3.45-103.4%101.87+103.8%49.98
PBT-87.87+45.6%-161.53-983.6%18.28+144.9%-40.69-218.5%34.35+140.6%-84.65
Tax30.5347.85-13.2718.24-9.0311.50
Equity19.4322.430000
OPM (%)-945.76-9.641.00-3.002.00-5.00
Net Profit-292.88-157.6%-113.68-2373.6%5+122.3%-22.46-188.7%25.32+134.6%-73.15
NPM (%)-3152.38-6.790.00-1.002.00-5.00
EPS (Rs)-2.620-100.0%0.22+122.0%-1-188.5%1.13+134.7%-3.26
CEPS-2.6200.22-11.13-3.26

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue0.01-100.0%005280.670
Other Income3.357.580.660.740.359.29
Total Income3.36-98.8%7.580.665.74281.029.29
Interest0.165.900018.7036.13
Expenditure-27.98+92.6%-64.51-32.21-6.24-377.78-97.17
PBDT000000
EBITDA-27.70+55.2%-58.53-32.21-1.04-61.89-60.70
Depreciation-0.11-0.080-0.20-16.52-0.34
EBIT-27.81+64.5%-58.61-32.21-1.24-78.41-61.04
PBT-24.62+74.6%-56.9356.60-0.51-96.75-87.88
Tax8.9019.7211.030.1833.5230.53
Equity19.4319.43022.4322.4319.43
OPM-732.74-751.068562.93-8.89-34.43-945.86
Net Profit-15.40+75.6%-67.9214.27-176.01-63.23-292.89
NPM-458.33-896.042158.85-3066.38-22.50-3152.45
EPS-0.79+72.0%-3.380-0.01-2.82-2.62

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 19-20FY 18-19
Revenue0-100.0%1,673.07-0.7%1,685.63+10.6%1,524.612,366.73-15.0%2,782.95
Other Income9.291.8913.0342.244.015.96
Total Income9.29-99.4%1,674.97-1.4%1,698.66+8.4%1,566.852,370.74-15.0%2,788.91
Expenditure-97.17+94.7%-1,836.50-9.3%-1,680.39-4.4%-1,609.27-2,333.27+14.5%-2,730.09
Interest-36.13-74.58-87.14-79.49-125.83-148.14
PBDT000000
EBITDA-60.70-129.4%-26.46-117.3%153.10+183.8%53.95220.06-16.7%264.26
Depreciation-0.34-62.39-60.72-59.12-60.77-63.26
EBIT-61.04+31.3%-88.85-196.2%92.38+1886.8%-5.17159.29-20.8%201
PBT-87.88+45.6%-161.53-984.1%18.27+143.1%-42.4237.47-36.3%58.82
Tax30.5347.85-13.2718.24-5.68-11.22
Equity19.4322.430000
OPM (%)-945.86-9.641.08-2.711.582.11
Net Profit-292.89-157.6%-113.68-2373.6%5+120.7%-24.1831.79-33.2%47.60
NPM (%)-3152.45-6.790.29-1.541.341.71
EPS (Rs)-2.620-100.0%0.22+120.4%-1.081.42-33.0%2.12
CEPS-2.6200.22-1.081.422.12

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

14
YearTypeAmountEx-Date
2020Final Dividend0.0518 Sep 2020
2020Final Dividend0.0511 Sep 2020
2019Final Dividend0.0519 Sep 2019
2018Final Dividend0.0519 Sep 2018
2017Final Dividend0.0520 Sep 2017
2016Final Dividend0.122 Sep 2016
2015Final Dividend0.122 Sep 2015
2014Final Dividend0.121 Aug 2014
2013Final Dividend0.119 Sep 2013
2012Final Dividend0.120 Sep 2012
2011Final Dividend0.121 Sep 2011
2010Interim Dividend0.2521 Jan 2010
2009Final Dividend0.103 Sep 2009
2008Final Dividend418 Sep 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers